I think the business is strong, but macro is getting worse.
- Our revenue is growing
- Increase in vendors de-risks the business
- Warehouse expansion allows growth
- Recurring software sales is good and opens opportunities too
- Hopefully DAS takes off, not sure who the big players are in the market, but probably lots of competition.
- I'm not sold on the IoT & 5G opportunities, but happy to be wrong
- Dividend is the same 5% (ex FC) as the bank, so need capital growth to offset.
- Forums
- ASX - By Stock
- DDR
- Ann: Q1 FY23 Market Update
Ann: Q1 FY23 Market Update, page-50
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DDR (ASX) to my watchlist
|
|||||
Last
$10.29 |
Change
0.000(0.00%) |
Mkt cap ! $1.856B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 452 | $10.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.78 | 317 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 452 | 10.600 |
1 | 25 | 10.510 |
1 | 100 | 10.500 |
1 | 950 | 10.310 |
2 | 169 | 10.300 |
Price($) | Vol. | No. |
---|---|---|
9.780 | 215 | 2 |
10.000 | 91 | 5 |
10.090 | 121 | 1 |
10.300 | 2800 | 2 |
10.310 | 300 | 1 |
Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
Featured News
DDR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online